Medicine and Dentistry
Patient
100%
Therapeutic Procedure
52%
Acute Coronary Syndrome
48%
Percutaneous Coronary Intervention
47%
Antiplatelet
32%
Myocardial Infarction
29%
Platelet Glycoprotein
20%
Abciximab
19%
Stent
18%
Fibrinogen Receptor
17%
Death
17%
Bleeding
17%
Drug-Eluting Stent
16%
ST Elevation
15%
Mortality
15%
Platelet
13%
Cardiovascular System
12%
Glycoprotein IIb/IIIa Inhibitors
12%
Association
12%
Heart Muscle Revascularization
11%
Tirofiban
10%
Consensus
10%
Revascularization
10%
Coronary Artery Disease
9%
Unstable Angina Pectoris
9%
Acetylsalicylic Acid
9%
Acute Heart Infarction
9%
Incidence
9%
Heparin
8%
Placebo
8%
Evaluation
8%
Hazard Ratio
8%
Vorapaxar
7%
Stent Thrombosis
7%
Complication
7%
Diabetes Mellitus
7%
Coronary Stenting
7%
Angiography
6%
Laboratory
6%
Follow up
6%
Receptor
6%
Odds Ratio
6%
Antithrombotic
5%
Age
5%
Clopidogrel
5%
Analysis
5%
Receptor Antagonist
5%
Blood Clot Lysis
5%
Antithrombotic Therapy
5%
Catheterization
5%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Coronary Syndrome
46%
Heart Infarction
36%
Fibrinogen Receptor
27%
Bleeding
23%
Antiplatelet
22%
Death
19%
Mortality
17%
Stent
17%
Abciximab
16%
Acute Heart Infarction
15%
Acetylsalicylic Acid
15%
Ticagrelor
13%
Drug
12%
Heparin
12%
Vorapaxar
11%
Clopidogrel
11%
Placebo
10%
Incidence
9%
Thrombin Receptor Antagonist
8%
Complication
8%
Monotherapy
8%
Anticoagulant Agent
7%
Clinical Trial
7%
Tirofiban
7%
Receptor
7%
Cerebrovascular Accident
7%
Fibrinolytic Agent
6%
Thrombin
6%
Coronary Artery Disease
6%
Clotting Time
5%
Randomized Clinical Trial
5%
ST Segment Elevation Myocardial Infarction
5%
Infarction
5%
Receptor Antagonist
5%
Diabetes Mellitus
5%
Atrial Fibrillation
5%
Nursing and Health Professions
Patient
38%
Percutaneous Coronary Intervention
20%
Acute Coronary Syndrome
8%
Heart Infarction
8%
Dual Antiplatelet Therapy
7%
Artificial Intelligence
7%
Mortality
7%
ReoPro
6%
Evaluation
6%
Procedures
6%
Incidence
5%
Bleeding
5%